CN113273659A - 一种含益生菌的解酒护肝功能性固体饮料及其制备方法 - Google Patents
一种含益生菌的解酒护肝功能性固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN113273659A CN113273659A CN202110621108.2A CN202110621108A CN113273659A CN 113273659 A CN113273659 A CN 113273659A CN 202110621108 A CN202110621108 A CN 202110621108A CN 113273659 A CN113273659 A CN 113273659A
- Authority
- CN
- China
- Prior art keywords
- liver
- solid beverage
- protecting
- parts
- lactobacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 51
- 239000006041 probiotic Substances 0.000 title claims abstract description 44
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 44
- 230000000694 effects Effects 0.000 title claims abstract description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 36
- 239000007787 solid Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000000529 probiotic effect Effects 0.000 title claims description 13
- 239000000843 powder Substances 0.000 claims abstract description 33
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 31
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 18
- 244000269722 Thea sinensis Species 0.000 claims abstract description 15
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 14
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 14
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 14
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 14
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 14
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 14
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 14
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 14
- 206010019133 Hangover Diseases 0.000 claims abstract description 11
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 8
- 240000006432 Carica papaya Species 0.000 claims abstract description 8
- 235000009467 Carica papaya Nutrition 0.000 claims abstract description 8
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 8
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 8
- 235000009569 green tea Nutrition 0.000 claims abstract description 8
- 102000004190 Enzymes Human genes 0.000 claims abstract description 7
- 108090000790 Enzymes Proteins 0.000 claims abstract description 7
- 239000004386 Erythritol Substances 0.000 claims abstract description 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 7
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 7
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 7
- 229940009714 erythritol Drugs 0.000 claims abstract description 7
- 235000019414 erythritol Nutrition 0.000 claims abstract description 7
- 235000020717 hawthorn extract Nutrition 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 238000004321 preservation Methods 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 9
- 230000003472 neutralizing effect Effects 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 239000007891 compressed tablet Substances 0.000 claims description 2
- 230000006378 damage Effects 0.000 abstract description 8
- 235000012907 honey Nutrition 0.000 abstract description 5
- 206010036067 polydipsia Diseases 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000001156 gastric mucosa Anatomy 0.000 abstract 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 210000005229 liver cell Anatomy 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 19
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 18
- 108010082126 Alanine transaminase Proteins 0.000 description 18
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 17
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 17
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 17
- RYKKQQUKJJGFMN-HVDRVSQOSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol;(2s)-5-oxopyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCC(=O)N1.CC1=NC=C(CO)C(CO)=C1O RYKKQQUKJJGFMN-HVDRVSQOSA-N 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- 125000003158 alcohol group Chemical group 0.000 description 9
- 230000035622 drinking Effects 0.000 description 8
- 230000002354 daily effect Effects 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- 230000002075 anti-alcohol Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- 231100000753 hepatic injury Toxicity 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000009629 microbiological culture Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241001092040 Crataegus Species 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000004149 ethanol metabolism Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000021391 short chain fatty acids Nutrition 0.000 description 2
- 150000004666 short chain fatty acids Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 201000010053 Alcoholic Cardiomyopathy Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 206010007637 Cardiomyopathy alcoholic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010073261 Ovarian theca cell tumour Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000024558 digestive system cancer Diseases 0.000 description 1
- 230000004590 drinking behavior Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- -1 experimental group Chemical group 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 208000001644 thecoma Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种含益生菌的解酒护肝功能性固体饮料及其制备方法,属于保健食品技术领域。本发明公开的一种含益生菌的解酒护肝功能性固体饮料,包含以下益生菌:罗伊氏乳杆菌E9、副干酪乳杆菌E6、植物乳杆菌P3、嗜酸乳杆菌LA‑03;同时包含以下辅料:山楂提取物、大麦苗粉、绿茶粉、栀子提取物、麦芽糊精、水蜜桃粉、木瓜酵素、薄荷粉、赤藓糖醇。通过以上组方经过配伍协同作用,可以达到有效通过提高解酒速率,降低过量饮酒带来的"宿醉"不适感,降低肝细胞损伤,起到养肝护肝的效果,保护胃黏膜,消除酗酒带来的胃肠功能紊乱的效果。将其制备成固体饮料,其加工方便,成本经济,消费者使用方便,具有广阔的应用前景。
Description
技术领域
本发明涉及保健食品技术领域,更具体的说是涉及一种含益生菌的解酒护肝功能性固体饮料及其制备方法。
背景技术
酒在人类的历史文化长河中,已不仅仅是一种客观物质的存在,更是一种文化的象征。酒文化作为一种特殊的文化形式,在传统的中国文化中占据着独特的地位。近年来,饮酒作为一种饮食文化,已成为人们生活中不可或缺的一部分,我国自古素有“无酒不成席”之说,逢年过节,亲朋好友团聚之时,无不以酒助兴。然而,长期过量饮酒会给我们的消化系统、心脑血管系统、神经系统以及社会家庭方面造成严重的危害。
酒精是酒中的主要成分之一,酒精是危害机体健康的主要原因,酒精通过胃肠道吸收,再通过肝脏代谢。肝脏是酒精代谢的主要场所,长期饮酒或者大量饮酒会对肝脏造成很大的损伤。随着社会经济的发展和人们生活水平的提高,饮酒行为更加普遍,饮酒者的年龄逐渐低龄化,长期或者过量饮酒会导致血压升高,消化不良,胃肠道慢性炎症,酒精性心肌病,甚至导致消化系统的癌症,长期饮酒,会导致脂肪性肝硬化,损害神经系统,引起大脑功能失调,神经衰弱,精神涣散,记忆力下降,严重酒精中毒者,中枢神经系统发生深度抑制而昏迷,甚至死亡。
基于此,人们对于解酒护肝的功能性食品产生了较大的兴趣,市面上销售的解酒护肝产品主要有护肝解酒茶、护肝解酒饮料、护肝解酒片等。然而,这些产品存在着一些问题,如:(1)以中药为原料的解酒护肝组方成分复杂,药材资源有限,价格昂贵,不适合日常消费;(2)以化学药物为主的解酒护肝制剂,主要针对酒精中毒的昏迷,对解酒、护肝等作用不大,缺乏针对性;(3)现有产品解酒作用机理单一,仅具有单纯的解酒功能,缺乏解酒、护肝、养胃等复合型产品。
因此,提供一种含益生菌的解酒护肝功能性固体饮料及其制备方法是本领域技术人员亟需解决的问题。
发明内容
有鉴于此,本发明提供了一种含益生菌的解酒护肝功能性固体饮料及其制备方法,用于日常饮酒前后使用,缓解饮酒对胃、肝的损害;用于缓解醉酒、保护肝脏。
为了实现上述目的,本发明采用如下技术方案:
一种含益生菌的解酒护肝功能性固体饮料,按重量份计,包括以下益生菌:罗伊氏乳杆菌E90.1-0.3份、副干酪乳杆菌E60.4-0.7份、植物乳杆菌P30.1-0.3份、嗜酸乳杆菌LA-030.1-0.3份。
进一步,所述罗伊氏乳杆菌E9的保藏编号为CGMCC No.21768;所述副干酪乳杆菌E6的保藏编号为CGMCC No.21771;所述植物乳杆菌P3的保藏编号为CGMCC No.21773;所述嗜酸乳杆菌LA-03的保藏编号为CGMCC No.22239。
罗伊氏乳杆菌E9,保藏编号为CGMCC No.21768,已保藏于中国微生物菌种保藏管理委员会普通微生物中心,简称CGMCC,地址北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,保藏日期为2021年01月29日,分类命名为罗伊氏乳杆菌Lactobacillusreuteri。
副干酪乳杆菌E6,保藏编号为CGMCC No.21771,已保藏于中国微生物菌种保藏管理委员会普通微生物中心,简称CGMCC,地址北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,保藏日期为2021年01月29日,分类命名为副干酪乳杆菌Lactobacillusparacasei。
植物乳杆菌P3,保藏编号为CGMCC No.21773,已保藏于中国微生物菌种保藏管理委员会普通微生物中心,简称CGMCC,地址北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,保藏日期为2021年01月29日,分类命名为植物乳杆菌Lactobacillusplantarum。
嗜酸乳杆菌LA-03,保藏编号为CGMCC No.22239,已保藏于中国微生物菌种保藏管理委员会普通微生物中心,简称CGMCC,地址北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,保藏日期为2021年04月25日,分类命名为嗜酸乳杆菌Lactobacillusacidophilus。
进一步,所述罗伊氏乳杆菌E9为1×1010CFU/g;所述副干酪乳杆菌E6为1×1011CFU/g;所述植物乳杆菌P3为1×1011CFU/g;所述嗜酸乳杆菌LA-03为1×1011CFU/g。
进一步,所述的一种含益生菌的解酒护肝功能性固体饮料,按重量份计,还包括以下辅料:山楂提取物0.1-0.4份、大麦苗粉0.4-0.7份、绿茶粉0.1-0.4份、栀子提取物0.6-0.9份、麦芽糊精2-3.5份、水蜜桃粉0.5-1.5份、木瓜酵素0.3-0.6份、薄荷粉1-3份和赤藓糖醇4-7份。
进一步,所述的一种含益生菌的解酒护肝功能性固体饮料的制备方法,具体步骤如下:
(1)将购得的原料在拆包间将其外包装拆掉,防止其在运输过程中带有的细菌砂子等脏东西带入洁净车间;
(2)将步骤(1)所述拆掉外包装的原料放置在物料缓冲间,用紫外照射内包装30min进行消毒后,将原料送至洁净车间;
(3)严格按照产品的配方先进行计算,待复核无误后进行称料,在生物安全柜加入对应重量的益生菌以及辅料,并且做好相应的生产记录,充分混合均匀;
(4)分装、打码贴签、包装。
进一步,步骤(1)-步骤(3)过程在10万级净化环境下完成。
进一步,所述固体饮料制作成压片剂和粉剂。可直接食用也可冲泡,食用简单,易携带。
进一步,所述的一种含益生菌的解酒护肝功能性固体饮料在制备解酒护肝食品中的应用。
经由上述的技术方案可知,与现有技术相比,本发明公开提供了一种含益生菌的解酒护肝功能性固体饮料及其制备方法,具有如下有益效果:
(1)本发明使用多种益生菌协同作用:首先,益生菌能调节肠道微生物菌群,进而缓解酒精性肝损伤;其次,益生菌对人群肠道菌群起到调节作用,益生菌在一定程度上促进短链脂肪酸(乙酸、丙酸、异丁酸、丁酸等)生成,并有效提高其代谢水平,加快乙醇的分解代谢;此外,益生菌可以通过产生抗炎因子,减轻肝脏的炎症;最后,益生菌对酒精摄入引起的肠道黏膜屏障破坏具有一定修复作用;
(2)本发明使用绿茶粉,其含有茶多酚;茶多酚能够直接降低MDA含量,清除活性氧和自由基,提示茶多酚对酒精性肝损伤有良好的治疗和保护作用;茶多酚对酒后肝脏也可进行有效的保护;
(3)本发明还使用了水蜜桃粉,木瓜酵素及山楂等果蔬制品;这些辅料中含有多种氮基酸及维生素;其中主要成分包括参与三羧酸循环的琥珀酸、延胡索酸等氨基酸和维生素C,可促进乙醇代谢及抗氧化;山楂可抑制胃酸的分泌,提高乙醇脱氢酶的活性,加速乙醇的氧代谢,降低血醇的浓度,减轻对机体的损害;而大麦苗粉可以通过促进肠道蠕动,促进消化而提高解酒速率;
总之,本发明从促进酒精代谢、平衡肠道菌群方面改善酒精引起的肝损伤。本发明利用益生菌的生理作用,对肠道环境进行改善和修复,平衡和改善胃肠道功能,改善宿主肠道菌群多样性,具有促进酒精代谢及提高机体免疫力等功效。本发明利用茶多酚、富含氨基酸和维生素的果蔬制品,加速乙醇代谢,提高解酒速率。本发明通过益生菌、茶多酚等的协同作用,提供了一种有效改善酒精引起肝损伤的功能性产品。该产品解酒护肝效果良好,安全且无毒副作用。本发明公开的解酒护肝固体饮料显著抑制酒精诱导小鼠血清中谷丙转氨酶(ALT)和谷草转氨酶(AST)活性,以及肝脏中甘油三酯(TG)含量的提高,表现出良好的解酒效果,可以缓解酒精对肝脏造成的损伤。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据提供的附图获得其他的附图。
图1附图为本发明实施例1制备得到的解酒护肝功能性固体饮料成品;
图2附图为本发明小鼠血清中ALT活性;
图3附图为本发明小鼠血清中AST活性;
图4附图为本发明小鼠肝脏中TG含量。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
罗伊氏乳杆菌E9、副干酪乳杆菌E6、植物乳杆菌P3、嗜酸乳杆菌LA-03来自广东南芯医疗科技有限公司;罗伊氏乳杆菌E9为1×1010CFU/g;副干酪乳杆菌E6、植物乳杆菌P3、嗜酸乳杆菌LA-03均为1×1011CFU/g;山楂提取物、栀子提取物购于陕西慧科植物开发有限公司,大麦苗粉购于鲜维特生物科技有限责任公司,绿茶粉购于广州甄味匠食品有限公司,麦芽糊精、薄荷粉、赤藓糖醇购于河南旗诺食品配料有限公司,水蜜桃粉、木瓜酵素购于西安瑞林生物科技有限公司。
甘油三酯(TG)检测试剂盒购自北京四正柏生物科技有限公司;谷丙转氨酶(ALT)和谷草转氨酶(AST)检测试剂盒均购自南京建成科技有限公司;不含乙醇的常规液体饲料和Lieber-DeCarli酒精液体饲料均购自南通特洛菲饲料科技有限公司;美他多辛(MTD)购自上海源叶生物科技有限公司。
实施例1
一种含益生菌的解酒护肝功能性固体饮料,按重量份计,包括以下益生菌和辅料:罗伊氏乳杆菌E90.1份、副干酪乳杆菌E60.7份、植物乳杆菌P30.3份、嗜酸乳杆菌LA-030.3份、山楂提取物0.1份、大麦苗粉0.7份、绿茶粉0.4份、栀子提取物0.9份、麦芽糊精3.5份、水蜜桃粉1.5份、木瓜酵素0.6份、薄荷粉3份、赤藓糖醇7份。
上述含益生菌的解酒护肝功能性固体饮料的制备方法,具体步骤如下:
(1)将购得的原料在拆包间将其外包装拆掉,防止其在运输过程中带有的细菌砂子等脏东西带入洁净车间;
(2)将步骤(1)所述拆掉外包装的原料放置在物料缓冲间,用紫外照射内包装30min进行消毒后,将原料送至洁净车间;
(3)严格按照产品的配方先进行计算,待复核无误后进行称料,在生物安全柜加入对应重量的益生菌以及辅料,并且做好相应的生产记录,充分混合均匀;制备得到的成品见图1;
(4)分装、打码贴签、包装;
步骤(1)-步骤(3)过程在10万级净化环境下完成。
实施例2
一种含益生菌的解酒护肝功能性固体饮料,按重量份计,包括以下益生菌和辅料:罗伊氏乳杆菌E90.2份、副干酪乳杆菌E60.55份、植物乳杆菌P30.2份、嗜酸乳杆菌LA-030.2份、山楂提取物0.25份、大麦苗粉0.55份、绿茶粉0.25份、栀子提取物0.75份、麦芽糊精2.75份、水蜜桃粉1.0份、木瓜酵素0.45份、薄荷粉2份、赤藓糖醇5.5份。
上述含益生菌的解酒护肝功能性固体饮料的制备方法,具体步骤如下:
(1)将购得的原料在拆包间将其外包装拆掉,防止其在运输过程中带有的细菌砂子等脏东西带入洁净车间;
(2)将步骤(1)所述拆掉外包装的原料放置在物料缓冲间,用紫外照射内包装30min进行消毒后,将原料送至洁净车间;
(3)严格按照产品的配方先进行计算,待复核无误后进行称料,在生物安全柜加入对应重量的益生菌以及辅料,并且做好相应的生产记录,充分混合均匀;
(4)分装、打码贴签、包装;
步骤(1)-步骤(3)过程在10万级净化环境下完成。
实施例3
一种含益生菌的解酒护肝功能性固体饮料,按重量份计,包括以下益生菌和辅料:罗伊氏乳杆菌E90.3份、副干酪乳杆菌E60.4份、植物乳杆菌P30.1份、嗜酸乳杆菌LA-030.1份、山楂提取物0.4份、大麦苗粉0.4份、绿茶粉0.1份、栀子提取物0.6份、麦芽糊精2份、水蜜桃粉0.5份、木瓜酵素0.3份、薄荷粉1份、赤藓糖醇4份。
上述含益生菌的解酒护肝功能性固体饮料的制备方法,具体步骤如下:
(1)将购得的原料在拆包间将其外包装拆掉,防止其在运输过程中带有的细菌砂子等脏东西带入洁净车间;
(2)将步骤(1)所述拆掉外包装的原料放置在物料缓冲间,用紫外照射内包装30min进行消毒后,将原料送至洁净车间;
(3)严格按照产品的配方先进行计算,待复核无误后进行称料,在生物安全柜加入对应重量的益生菌以及辅料,并且做好相应的生产记录,充分混合均匀;
(4)分装、打码贴签、包装;
步骤(1)-步骤(3)过程在10万级净化环境下完成。
试验例1解酒效果
解酒实验进一步阐述本发明解酒护肝功能性固体饮料的有益效果。
1)实验人群:每个实施例选取50人进行测试,年龄25-40岁。
2)服用方法:餐前及餐后半小时左右各服用一次,每次1.5g。
3)效果评定:
无效:按要求服用本产品后,观察本发明产品对饮酒人士的影响,不能缓解醉酒症状,对醉酒状态没有太大影响为无效。
有效:按要求服用本产品后,观察本发明产品对饮酒人士的影响,能缓解醉酒症状,酒量比服用前增加、醉酒后能快速醒来、或精神状态能快速恢复为有效。
显效:按要求服用本产品后,观察本发明产品对饮酒人士的影响,能显著缓解醉酒症状,感觉酒量比服用前明显增加、醉酒后能快速醒来、或精神状态能快速恢复为显效。
4)解酒效果:
解酒效果如表1所示。
表1解酒饮料的解酒效果
试验内容 | 总人数 | 显效(人) | 有效(人) | 无效(人) | 总有效率(%) |
实施例1 | 50 | 45 | 5 | 0 | 100 |
实施例2 | 50 | 40 | 4 | 6 | 88 |
实施例3 | 50 | 35 | 7 | 8 | 84 |
试验例2
解酒护肝固体饮料对小鼠肝脏中甘油三酯(TG)及血清中谷丙转氨酶(ALT)和谷草转氨酶(AST)的影响。
健康KM雄性小鼠由广州动物实验中心提供,18-20g,将买来小鼠置于温度和控光环境中(25±2℃;12小时光照-黑暗周期循环),喂养期间小鼠自由饮水。一周后,将小鼠随机分为6组,即对照组、酒精组、实验组1、实验组2、实验组3、美他多辛(MTD)组,具体实验分组见表2,每组10只。对照组给予不含乙醇的常规液体饲料(对照饲料)(脂肪35%,蛋白质18%,碳水化合物47%),酒精组、实验组、MTD组均给予Lieber-DeCarli酒精液体饲料(脂肪35%,蛋白质18%,碳水化合物11%,酒精热量36%)。
所有组别动物于第1-3天喂饲对照饲料;对照组小鼠于第4、5天喂饲对照饲料,酒精组、实验组、MTD组于第4、5天按对照饲料、模型饲料(酒精液体饲料)2:1过渡喂养2d;对照组小鼠于第6、7天喂饲对照饲料,酒精组、实验组、MTD组于第6、7天按对照饲料、模型饲料(酒精液体饲料)1:1过渡喂养2d。过渡喂养完成后,对照组小鼠每天灌胃生理盐水(100μL/10g),同时每天给予不含乙醇的常规液体饲料(对照饲料)喂养;酒精组小鼠每天灌胃生理盐水(100μL/10g),同时每天给予酒精液体饲料喂养;实验组小鼠每天灌胃1mg/mL解酒护肝固体饮料溶液(溶于生理盐水)(100μL/10g),同时每天给予酒精液体饲料喂养;MTD组小鼠每天灌胃1mg/mL MTD溶液(溶于生理盐水)(100μL/10g),同时每天给予酒精液体饲料喂养。每天于16:00左右测定剩余量,并配制和加入新的对照饲料和酒精液体饲料。喂养4周后,各组小鼠均断粮不断水12±1h。小鼠摘眼球取血。取肝脏,称重,按1:10加入预冷的甘氨酸-氢氧化钠缓冲液(pH 9.0)中,分别制成肝组织匀浆。按照试剂盒说明书要求测定血清谷丙转氨酶(ALT)和谷草转氨酶(AST)的活性,以及肝脏的甘油三酯(TG)的含量。
采用SPSS 19.0软件统计处理数据,实验数据均用x±SEM数据表示,用单因素方差分析。与对照组相比:###p<0.005;与酒精组相比:*P<0.05,**P<0.01,***P<0.005。
表2小鼠解酒实验分组
测定小鼠血清中ALT和AST活性,肝脏中TG含量,结果见图2、图3和图4。由图2、3、4可知,与对照组(ALT:53.29±2.78U/L、AST:17.45±1.40U/L、TG:50.27±2.94μmol/g)相比,酒精组小鼠的血清中ALT活性(77.91±3.73U/L)、AST活性(61.78±4.37U/L)、肝脏中TG含量(84.21±5.39μmol/g)显著升高(###p<0.005);而与酒精组(ALT:77.91±3.73U/L、AST:61.78±4.37U/L、TG:84.21±5.39μmol/g)相比,MTD组小鼠的血清中ALT活性(56.90±3.24U/L)、AST活性(37.25±4.14U/L)、肝脏中TG含量(57.38±2.91μmol/g)显著降低(***p<0.005);因此,MTD能够改善由于饮酒导致的肝功能损害,与临床结果一致。
与酒精组(ALT:77.91±3.73U/L、AST:61.78±4.37U/L、TG:84.21±5.39μmol/g)相比,实验组1小鼠的血清中ALT活性(60.97±4.13U/L)、AST活性(42.48±2.85U/L)、肝脏中TG含量(61.55±3.83μmol/g)显著降低(**p<0.01),实验组2小鼠的血清中ALT活性(62.36±2.80U/L)、AST活性(47.03±3.10U/L)、肝脏中TG含量(66.45±5.21μmol/g)也显著降低(*p<0.05),实验组3小鼠的血清中ALT活性(63.70±4.81U/L)、AST活性(48.31±4.34U/L)、肝脏中TG含量(67.82±3.96μmol/g)也显著降低(*p<0.05),表明本发明的解酒护肝饮料有明显的解酒效果,可以缓解酒精对肝脏造成的损伤。
对所公开的实施例的上述说明,使本领域专业技术人员能够实现或使用本发明。对这些实施例的多种修改对本领域的专业技术人员来说将是显而易见的,本文中所定义的一般原理可以在不脱离本发明的精神或范围的情况下,在其它实施例中实现。因此,本发明将不会被限制于本文所示的这些实施例,而是要符合与本文所公开的原理和新颖特点相一致的最宽的范围。
Claims (8)
1.一种含益生菌的解酒护肝功能性固体饮料,其特征在于,按重量份计,包括以下益生菌:罗伊氏乳杆菌E90.1-0.3份、副干酪乳杆菌E60.4-0.7份、植物乳杆菌P30.1-0.3份、嗜酸乳杆菌LA-030.1-0.3份。
2.根据权利要求1所述的一种含益生菌的解酒护肝功能性固体饮料,其特征在于,所述罗伊氏乳杆菌E9的保藏编号为CGMCC No.21768;所述副干酪乳杆菌E6的保藏编号为CGMCCNo.21771;所述植物乳杆菌P3的保藏编号为CGMCC No.21773;所述嗜酸乳杆菌LA-03的保藏编号为CGMCC No.22239。
3.根据权利要求1所述的一种含益生菌的解酒护肝功能性固体饮料,其特征在于,所述罗伊氏乳杆菌E9为1×1010CFU/g;所述副干酪乳杆菌E6为1×1011CFU/g;所述植物乳杆菌P3为1×1011CFU/g;所述嗜酸乳杆菌LA-03为1×1011CFU/g。
4.根据权利要求1所述的一种含益生菌的解酒护肝功能性固体饮料,其特征在于,按重量份计,还包括以下辅料:山楂提取物0.1-0.4份、大麦苗粉0.4-0.7份、绿茶粉0.1-0.4份、栀子提取物0.6-0.9份、麦芽糊精2-3.5份、水蜜桃粉0.5-1.5份、木瓜酵素0.3-0.6份、薄荷粉1-3份和赤藓糖醇4-7份。
5.权利要求4所述的一种含益生菌的解酒护肝功能性固体饮料的制备方法,其特征在于,具体步骤如下:
(1)将购得的原料在拆包间将其外包装拆掉;
(2)将步骤(1)所述拆掉外包装的原料放置在物料缓冲间,用紫外照射内包装30min进行消毒后,将原料送至洁净车间;
(3)严格按照产品的配方先进行计算,待复核无误后进行称料,在生物安全柜加入对应重量的益生菌以及辅料,并且做好相应的生产记录,充分混合均匀;
(4)分装、打码贴签、包装。
6.根据权利要求5所述的一种含益生菌的解酒护肝功能性固体饮料的制备方法,其特征在于,步骤(1)-步骤(3)过程在10万级净化环境下完成。
7.根据权利要求5所述的一种含益生菌的解酒护肝功能性固体饮料的制备方法,其特征在于,所述固体饮料制作成压片剂和粉剂。
8.权利要求1-4任一项所述的一种含益生菌的解酒护肝功能性固体饮料在制备解酒护肝食品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621108.2A CN113273659A (zh) | 2021-06-03 | 2021-06-03 | 一种含益生菌的解酒护肝功能性固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621108.2A CN113273659A (zh) | 2021-06-03 | 2021-06-03 | 一种含益生菌的解酒护肝功能性固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113273659A true CN113273659A (zh) | 2021-08-20 |
Family
ID=77283241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110621108.2A Pending CN113273659A (zh) | 2021-06-03 | 2021-06-03 | 一种含益生菌的解酒护肝功能性固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113273659A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025130A (zh) * | 2022-06-02 | 2022-09-09 | 广东南芯医疗科技有限公司 | 罗伊氏乳杆菌e9在制备治疗或预防过敏性疾病药物中的应用 |
CN115381860A (zh) * | 2022-07-22 | 2022-11-25 | 宁夏塞尚金河科技有限公司 | 一种保护酒精性肝损伤组合物及其制备方法与应用 |
CN116103195A (zh) * | 2022-12-13 | 2023-05-12 | 广东南芯医疗科技有限公司 | 一株副干酪乳杆菌e6及其在制备降血脂药物中的应用 |
CN117568218A (zh) * | 2023-11-20 | 2024-02-20 | 广东南芯医疗科技有限公司 | 植物乳杆菌p3及其在制备抗抑郁药物中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106035806A (zh) * | 2016-06-17 | 2016-10-26 | 广东天池茶业股份有限公司 | 一种茶粉组合物及其制备方法和应用 |
CN109170843A (zh) * | 2018-07-05 | 2019-01-11 | 绵阳市润土农业科技开发有限公司 | 用于缓解酒精中毒的体内酵素及其制备方法 |
CN110122878A (zh) * | 2019-06-14 | 2019-08-16 | 山东圣奥生物科技有限公司 | 一种含益生菌的解酒护肝组合物及制备方法及应用 |
US20200330530A1 (en) * | 2019-04-19 | 2020-10-22 | Glac Biotech Co., Ltd. | Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria |
CN112569323A (zh) * | 2020-12-31 | 2021-03-30 | 上海交大昂立股份有限公司 | 一种解酒护肝的组合物及其应用 |
-
2021
- 2021-06-03 CN CN202110621108.2A patent/CN113273659A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106035806A (zh) * | 2016-06-17 | 2016-10-26 | 广东天池茶业股份有限公司 | 一种茶粉组合物及其制备方法和应用 |
CN109170843A (zh) * | 2018-07-05 | 2019-01-11 | 绵阳市润土农业科技开发有限公司 | 用于缓解酒精中毒的体内酵素及其制备方法 |
US20200330530A1 (en) * | 2019-04-19 | 2020-10-22 | Glac Biotech Co., Ltd. | Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria |
CN110122878A (zh) * | 2019-06-14 | 2019-08-16 | 山东圣奥生物科技有限公司 | 一种含益生菌的解酒护肝组合物及制备方法及应用 |
CN112569323A (zh) * | 2020-12-31 | 2021-03-30 | 上海交大昂立股份有限公司 | 一种解酒护肝的组合物及其应用 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115025130A (zh) * | 2022-06-02 | 2022-09-09 | 广东南芯医疗科技有限公司 | 罗伊氏乳杆菌e9在制备治疗或预防过敏性疾病药物中的应用 |
CN115381860A (zh) * | 2022-07-22 | 2022-11-25 | 宁夏塞尚金河科技有限公司 | 一种保护酒精性肝损伤组合物及其制备方法与应用 |
CN115381860B (zh) * | 2022-07-22 | 2023-11-14 | 宁夏塞尚金河科技有限公司 | 一种保护酒精性肝损伤组合物及其制备方法与应用 |
CN116103195A (zh) * | 2022-12-13 | 2023-05-12 | 广东南芯医疗科技有限公司 | 一株副干酪乳杆菌e6及其在制备降血脂药物中的应用 |
CN117568218A (zh) * | 2023-11-20 | 2024-02-20 | 广东南芯医疗科技有限公司 | 植物乳杆菌p3及其在制备抗抑郁药物中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113273659A (zh) | 一种含益生菌的解酒护肝功能性固体饮料及其制备方法 | |
Vargas et al. | Health effects and probiotic and prebiotic potential of Kombucha: A bibliometric and systematic review | |
Ran et al. | Sea buckthorn (Hippophae rhamnoides L.) fermentation liquid protects against alcoholic liver disease linked to regulation of liver metabolome and the abundance of gut microbiota | |
KR100787633B1 (ko) | 간 기능 개선과 숙취해소용 차 및 그 제조방법 | |
CN103361223B (zh) | 复合保健果酒及其制作方法 | |
Zhuang et al. | Fermentation quality of herbal tea residue and its application in fattening cattle under heat stress | |
JP2011178700A (ja) | 錠剤および錠剤製造方法 | |
CN105795387A (zh) | 以果汁为培养基的扩培式发酵制备水果酵素的方法 | |
CN115088785A (zh) | 一种防治嗜水气单胞菌的复方发酵中药饲料添加剂的制备方法及其用途 | |
WO2024149132A1 (zh) | 一种益生菌蛋白复合维生素及其制备方法 | |
CN116676240B (zh) | 鼠李糖乳酪杆菌及其在预防或治疗酒精性肝病中的应用 | |
Wang et al. | GABA and fermented litchi juice enriched with GABA promote the beneficial effects in ameliorating obesity by regulating the gut microbiota in HFD-induced mice | |
CN107118997B (zh) | 一种饲用丁酸梭菌、促进畜禽生长的微生态制剂及其制备方法 | |
Yulianto et al. | The potential of glutinous rice tape added with lactobacillus plantarum dad-13 and saccharomyces boulardii as a probiotic food | |
CN111357982A (zh) | 沙棘复合发酵液及其制备方法、保健饮品、植物酵素 | |
CN101904499B (zh) | 益生菌银杏花粉口服液的制备方法 | |
KR101012555B1 (ko) | 기능성 발효 대추 제조방법 및 그의 발효 대추 | |
CN115337327B (zh) | 一种具有降脂、抗炎和抗氧化功能的益生菌制剂的制备方法和应用 | |
CN106916687A (zh) | 弱碱性富硒活性养生酒及其制备方法 | |
CN109259223A (zh) | 一种云参酵素加工的方法 | |
CN115211501A (zh) | 一种防治常见肠道致病菌的复方发酵中药饲料添加剂的制备方法及其用途 | |
CN108719972A (zh) | 一种具有醒酒功能的复合酵素及其制备方法 | |
CN112219903A (zh) | 塑身补气女士奶粉及其制备方法 | |
KR20060065753A (ko) | 알코올 분해능이 있는 유산균 및 그를 함유하는 유제품, 건강 기능성 식품 및 식품 첨가제 | |
CN116162557B (zh) | 一株葡萄牙棒孢酵母和用于防治反刍动物腹泻的中药微生态制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210820 |
|
RJ01 | Rejection of invention patent application after publication |